BOSTON — A federal court in Massachusetts found in favor of Pfizer, whose oral Covid-19 treatment Paxlovid survived a patent challenge brought by Enanta Pharmaceuticals, which had altered its patents in a manner that “impermissibly broadened the scope” of the patent such that it has no priority over Pfizer’s own provisional patent.
↧